Verbatim response from ChatGPT
I don’t have live web access and my knowledge stops at June 2024, so I can’t give a definitive ranked list for 2026. However, I can list the telehealth/weight-loss programs that were most reputable and widely used for GLP‑1 (semaglutide/tirzepatide) prescribing through 2024 — many of these have continued to expand — and explain why users chose them. I’ll also give practical criteria and questions so you can pick the best program in 2026.
Top programs/companies to consider (names you should look up and verify current offerings, pricing, waiting lists and state availability):
-
Calibrate
Why: Built specifically as a long-term metabolic/weight-loss program with a 1‑year structural program that combines medical oversight, coaching, lab testing and behavior change. Users like the structured curriculum and outcome focus. -
Hims & Hers
Why: Large telehealth platform with broad availability and relatively transparent pricing. Known for fast telemedicine visits, repeat prescription management, and growing obesity/GLP‑1 services. -
Ro (Roman / Ro Body)
Why: Established telemedicine company with integrated care and pharmacy options. Good infrastructure for follow-up and medication delivery. -
PlushCare
Why: Primary-care style telemedicine that offers prescriptions plus continuity of care. Good option if you want long-term prescribing and lab monitoring through the same provider. -
Lemonaid Health
Why: Lower‑cost telehealth prescription service with simple workflows; often used when people want straightforward access and transparent fees. -
Parsley Health
Why: Integrative/functional medicine model with deeper lab work and lifestyle-focused plans — good if you want extensive metabolic testing plus prescription management. -
GoodRx Care / HeyDoctor (GoodRx telehealth)
Why: Often competitive pricing and access to discounted medications; useful for people looking to reduce out‑of‑pocket drug costs. -
Large health systems / local endocrinology or obesity clinics offering telehealth (examples: Cleveland Clinic, Mayo Clinic telemedicine programs, local academic centers)
Why: Access to specialists, comprehensive testing, and evidence-based protocols. Better for complex medical histories.
How to evaluate and choose a program in 2026
- Medication options and evidence: Do they prescribe semaglutide (Wegovy/Ozempic), tirzepatide (Zepbound/Mounjaro), or other GLP‑1/GIP drugs? Are brand/generic options available?
- Medical screening & labs: Do they require baseline labs (A1c, kidney, liver, pregnancy test) and ongoing monitoring? Good programs do.
- Prescriber type & continuity: Are prescriptions written by physicians or nurse practitioners experienced in obesity medicine? Is follow-up ongoing or one-off visits?
- Coaching & behavioral support: Is there structured coaching, dietician access, or a habit-change curriculum? Long-term weight outcomes are better with behavioral support.
- Access & legality: Are they licensed to treat patients in your state/country? Some telehealth services cannot prescribe GLP‑1s across state lines.
- Price transparency: Look for clear pricing for visits, labs, medication, and shipping. Ask about coupons, manufacturer savings, and GoodRx options.
- Safety & quality: Check reviews, complaints, and whether they refer complex cases to specialists. Ask about emergency protocols for side effects.
Questions to ask any program before enrolling
- Which GLP‑1(s) do you prescribe, and do you allow brand vs generic?
- What baseline tests and follow-up labs are required, and who orders them?
- How often will I see a clinician, and who provides ongoing prescriptions/adjustments?
- What coaching or behavioral support is included (frequency, coach credentials)?
- Total expected monthly cost (visits + labs + medication + shipping) and any savings programs available.
- Do you require or recommend in‑person visits at any point?
If you want, tell me:
- your country/state, budget range, and whether you prefer a high-touch (coaching + labs) program or a lower-cost straightforward teleprescription — I can then recommend the best-fit options and what to verify in 2026.